BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Webinar Case Study: ‘Companion Informatics’ to Automate Immunotherapy Manufacturing and Treatment

Webinar Case Study: ‘Companion Informatics’ to Automate Immunotherapy Manufacturing and Treatment

February 13, 2019 By Cade Hildreth (CEO) Leave a Comment

L7 Informatics is honored to host a Free Webinar exploring a Case Study related to “‘Companion Informatics’ to Automate Immunotherapy Manufacturing and Treatment.”

Discover class-defining bioproduction tools.

Webinar: Companion Informatics’ to Automate Immunotherapy Manufacturing & Treatment

L7 InformaticsGenomics-driven precision medicine and regenerative medicine including cell and gene therapies require a new category of “companion informatics” software that automates and synchronizes complex data and process management. This software is applicable throughout the life-cycle of these complex therapeutics as they make their way from bench to clinical trials to bedside.

By connecting to disparate software systems, lab instrumentation, sequencing machines, and process equipment, L7’s Enterprise Science Platform (ESP) provides end-to-end process automation, real-time data capture, needle-to-needle chain-of-identity, actionable dashboards, and reports. ESP platform provides an integrated NGS LIMS, bio-informatics processing, AI/ML integration, sample management, inventory management, freezer management, quality management, and electronic batch records all within a regulatory compliant platform (cGMP, GAMP, CAP/CLIA, HIPAA).

bitbio

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immuno-oncology cell therapy company, is using the ESP platform from L7 to streamline its research, clinical, and manufacturing operations. It will showcase L7’s ESP’s implementation at Gradalis, where manual batch records and paper-based quality management with manual calculations are being replaced with the ESP automation platform.

Ernest Bognar, COO of Gradalis
Ernest Bognar, COO of Gradalis

Ernest Bognar is Gradalis’ Chief Operating Officer. Prior to Gradalis, he was General Manager of Dendreon’s manufacturing facility, which was developed to meet the anticipated clinical and commercial manufacturing needs for Provenge (sipuleucel-T) and other active immunotherapy product candidates in development.

iPSC-derived cardiomyocte therapy

Prior to Dendreon, Ernie served as Vice President of Manufacturing at Apptec Laboratory Services, where he managed and grew a mammalian cell-based contract manufacturing business unit. Prior to that, he was Senior Director of Commercial Manufacturing for ImClone Systems, where he managed a biopharmaceutical startup operation that produced Erbitux (cetuximab) for the treatment of colorectal cancer.

Pluristyx

Ernie also served as Manufacturing Head at Baxter Healthcare’s Hyland-Immuno Division for the production of Recombinate (FactorVIII) and held key manufacturing positions at Cellex Biosciences, Verax, Charles River Biotech, KC Biological, and Ayerst Research Laboratories. He received his Bachelor of Science degree in in vitro cell biology from the State University of New York of Arts and Sciences at Plattsburgh and his Cell Biology Certificate from W. Alton Jones Cell Science Center.

Webinar Date and Time: 

Thursday, February 21, 2019 1:00 pm
Eastern Standard Time (New York, GMT-05:00)

Thursday, February 21, 2019 10:00 am
Pacific Standard Time (San Francisco, GMT-08:00)

Thursday, February 21, 2019 7:00 pm
Europe Time (Paris, GMT+01:00)

Speaker: 

Ernest Bognar, COO of Gradalis

Duration:

1 Hour

To register for this exciting webinar on the use of companion informatics to automate immunotherapy manufacturing and treatment, click here.

 

5/5 - (1 vote)

Filed Under: Cell Therapy Tagged With: Gradalis, immunotherapy, L7 Informatics, webinar

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

PolarityTE RMAT

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

What Is An RMAT? List of Publicly Announced RMAT Designations (64)

i-peaces-cell-manufacturing

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.